This is a preview of subscription content, log in via an institution to check access.
References
Kossoff EH, Singer HS. Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs 2001; 3 (5): 355–63
Hanna PA, Janjua FN, Constant CF, et al. Bilineal transmission in Tourette syndrome. Neurology 1999; 53: 813–8
Mason A, Banerjee S, Eapen V, et al. The prevalence of Tourette syndrome in a mainstream school population. Dev Med Child Neurol 1998 May; 40 (5): 292–6
Jankovic J. Tourette’s syndrome. N Engl J Med 2001 Oct; 345 (16): 1184–92
Sallee FR, Nesbitt L, Jackson C, et al. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette disorder. Am J Psychiatry 1997; 8: 1057–62
Bruggeman R, van der Linden C, Buitelaar JK, et al. Risperidone versus pimozide in Tourette’s disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001; 62 (1): 50–6
Eapen V, Robertson MM. Comorbid obsessive-compulsive disorder and Tourette syndrome: therapeutic interventions. CNS Drugs 2001 Mar; 13 (3): 173–13
Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive compulsive disorder. J Clin Psychiatry 1999 Feb; 60 (2): 101–6
Rights and permissions
About this article
Cite this article
Tourette syndrome: a range of therapeutic options now available. Drugs Ther. Perspect 18, 15–18 (2002). https://doi.org/10.2165/00042310-200218020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200218020-00006